Brown Advisory Inc. lifted its holdings in Cooper Companies Inc (NYSE:COO) by 4.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 19,576 shares of the medical device company’s stock after purchasing an additional 843 shares during the quarter. Brown Advisory Inc.’s holdings in Cooper Companies were worth $4,982,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of COO. Vanguard Group Inc boosted its stake in Cooper Companies by 0.6% during the third quarter. Vanguard Group Inc now owns 5,041,468 shares of the medical device company’s stock worth $1,397,243,000 after buying an additional 31,280 shares during the period. BlackRock Inc. boosted its stake in Cooper Companies by 7.1% during the fourth quarter. BlackRock Inc. now owns 3,732,729 shares of the medical device company’s stock worth $949,981,000 after buying an additional 246,088 shares during the period. FIL Ltd boosted its stake in Cooper Companies by 16.1% during the third quarter. FIL Ltd now owns 815,901 shares of the medical device company’s stock worth $226,127,000 after buying an additional 113,054 shares during the period. Putnam Investments LLC boosted its stake in Cooper Companies by 228.5% during the third quarter. Putnam Investments LLC now owns 622,865 shares of the medical device company’s stock worth $172,627,000 after buying an additional 433,242 shares during the period. Finally, Northern Trust Corp boosted its stake in Cooper Companies by 3.7% during the fourth quarter. Northern Trust Corp now owns 588,406 shares of the medical device company’s stock worth $149,749,000 after buying an additional 20,854 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.
COO has been the subject of several recent analyst reports. Jefferies Financial Group lifted their price objective on shares of Cooper Companies to $330.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. KeyCorp reaffirmed a “buy” rating on shares of Cooper Companies in a research note on Sunday, December 9th. Zacks Investment Research raised shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $317.00 price objective for the company in a research note on Friday, March 8th. Oppenheimer set a $282.00 price objective on shares of Cooper Companies and gave the stock a “hold” rating in a research note on Friday, December 7th. Finally, Raymond James lifted their price objective on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $307.90.
In other news, insider Robert D. Auerbach sold 2,272 shares of the business’s stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $292.22, for a total transaction of $663,923.84. Following the completion of the sale, the insider now directly owns 2,538 shares of the company’s stock, valued at $741,654.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stanley Md Zinberg sold 740 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $290.03, for a total transaction of $214,622.20. Following the sale, the director now directly owns 17,421 shares of the company’s stock, valued at $5,052,612.63. The disclosure for this sale can be found here. Insiders have sold 3,811 shares of company stock valued at $1,107,763 over the last three months. Insiders own 1.70% of the company’s stock.
Shares of COO opened at $295.23 on Friday. The firm has a market cap of $14.58 billion, a PE ratio of 25.67, a P/E/G ratio of 2.27 and a beta of 0.88. Cooper Companies Inc has a 12-month low of $216.47 and a 12-month high of $299.00. The company has a quick ratio of 0.75, a current ratio of 1.27 and a debt-to-equity ratio of 0.49.
Cooper Companies (NYSE:COO) last issued its earnings results on Tuesday, March 5th. The medical device company reported $2.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.38. Cooper Companies had a net margin of 14.22% and a return on equity of 17.56%. Analysts predict that Cooper Companies Inc will post 12.01 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This piece was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2019/03/17/brown-advisory-inc-acquires-843-shares-of-cooper-companies-inc-coo.html.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Further Reading: How to calculate the intrinsic value of a stock
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.